Investor Calendar Invites You to the NeoGenomics Fourth Quarter and Fiscal Year 2015 Earnings Conference Call and Webcast Live on Tuesday March 1, 2016

FORT MYERS, FL / ACCESSWIRE / February 29, 2016 / NeoGenomics, Inc. (NASDAQ: NEO) will host a conference call and live webcast to discuss the results of the fourth quarter and fiscal year 2015, to be held Tuesday, March 1, 2016 at 11:00 AM Eastern Time.

To participate in this event, dial 877-407-0782 domestically, or 201-689-8567 internationally, approximately 5 to 10 minutes before the beginning of the call. Additionally, you can listen to the event online at www.investorcalendar.com/IC/CEPage.asp?ID=174667 as well as via the NeoGenomics website (www.neogenomics.com).

If you are unable to participate during the live webcast, the event archive will be available at www.investorcalendar.com or www.neogenomics.com.

You may access the teleconference replay by dialing 877-660-6853 domestically or 201-612-7415 internationally, referencing conference ID # 13629440. The replay will be available beginning approximately 2 hours after the completion of the live event, ending at midnight Eastern on March 15, 2016.

About NeoGenomics, Inc.

NeoGenomics, Inc. is a high-complexity CLIA-certified clinical laboratory that specializes in cancer genetics diagnostic testing, the fastest growing segment of the laboratory industry. The company’s testing services include cytogenetics, fluorescence in-situ hybridization (FISH), flow cytometry, immunohistochemistry, anatomic pathology and molecular genetic testing.

Headquartered in Fort Myers, FL, NeoGenomics has laboratories in Nashville, TN; Aliso Viejo, Irvine, Fresno and West Sacramento CA; and Tampa and Fort Myers, FL. NeoGenomics services the needs of pathologists, oncologists, other clinicians and hospitals throughout the United States. For additional information about NeoGenomics, visit http://www.neogenomics.com.

Interested parties can also access investor relations material from Hawk Associates at http://www.hawkassociates.com or neogenomics@hawk.com.

SOURCE: Investor Calendar

ReleaseID: 437321